- Advertisement -
The U.S. Food and Drug Administration has approved the expanded use of Axsome Therapeutics’ Auvelity (dextromethorphan hydrobromide and bupropion hydrochloride) extended-release tablets to treat adults with agitation associated with dementia due to Alzheimer’s disease.
…
